QIAGEN N.V.: Release of a capital market information

QIAGEN N.V.  / Share buyback

21.09.2012 22:00

Dissemination of a Post-admission Duties announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Disclosure according to Art. 4 Para. 2 
of the Regulation (EC) No. 2273/2003

The share repurchase program, announced by QIAGEN N.V. in an ad hoc
announcement dated July 24, 2012, will commence on October 1, 2012.

In the time period until November 5, 2012, a first tranche of common shares
of the Company having a total purchase price of up to the EUR equivalent
amount of USD 10 million (without ancillary purchasing costs) shall be
repurchased on the electronic trading platform of the Frankfurt Stock
Exchange (XETRA ) exclusively. The first tranche is limited by the
repurchase of a total number of max. 570,000 shares. The maximum purchase
price per share (excluding ancillary purchase costs) will not exceed by
more than 10% the EUR equivalent of the average closing price for the last
five trading days prior to the day of purchase on the NASDAQ Global Select
Market.

The purpose of the share repurchase is to hold the shares in treasury in
order to satisfy obligations from exchangeable debt instruments and/or
employee share-based remuneration plans. The Managing Board of QIAGEN N.V.,
upon authorization of the Supervisory Board, is thus exercising the
authorization by the Annual General Meeting on June 27, 2012 to acquire own
shares. The repurchase of additional tranches will be decided separately
and details will be announced separately.

The repurchase program will be carried out on behalf and account of QIAGEN
N.V. through a financial institution commissioned by the Company. The
financial institution will decide on the timing of the share purchase
independently, without being influenced by the Company.

The first tranche of the share repurchase program will be implemented in
accordance with the trading terms of Art. 5 of the Regulation No. 2273/2003
of the Commission of December 22, 2003 (EC Regulation). In accordance with
the EC Regulation, no purchase price may be paid that exceeds the price of
the last independent trade or the highest current independent bid on the
Frankfurt Stock Exchange. The higher of both values is decisive. In
accordance with the EC Regulation, no more than 25% of the average daily
volume of shares on the Frankfurt Stock Exchange may be acquired. The
average volume of shares is based on the average daily volume traded in the
twenty stock exchange trading days preceding the date of the purchase.

The share repurchase program may be suspended and resumed at any time, in
line with applicable statutory regulations.

The transactions will be announced in a manner compliant with the
requirements of Art. 4, Para. 4 of the EC Regulation no later than on the
seventh trading day following their conclusion.

In addition, QIAGEN N.V. will provide regular updates on the progress of
the share repurchase program at www.qiagen.com.

Venlo, September 21, 2012

The Managing Board 

###

Contacts:

QIAGEN

Investor Relations                    Public Relations
John Gilardi         +49 2103 29      Dr. Thomas           +49 2103 29
                     11711            Theuringer           11826
Albert F. Fleury     +1 240 686 7400  e-mail:
                                      pr@qiagen.com
e-mail:
ir@qiagen.com






21.09.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      QIAGEN N.V.
              Spoorstraat 50
              5911 KJ Venlo
              Netherlands
Internet:     www.qiagen.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------